ALPHARETTA, Ga.--(BUSINESS WIRE)--April 26, 2006--First Horizon Pharmaceutical Corporation (NASDAQ:FHRX - News):First Horizon Pharmaceutical Corporation (NASDAQ:FHRX - News), a specialty pharmaceutical company, today announced performance for the first quarter ended March 31, 2006. Net revenues for the first quarter of 2006 increased 62% to $66.5 million from $41.0 million in the first quarter of 2005. Net income for the first quarter of 2006, which includes after-tax stock-based compensation expense of $1.4 million, increased 20% to $9.1 million from $7.6 million in the same period of 2005. Adjusted diluted earnings per share (EPS), excluding stock compensation expense of $0.03 for the first quarter of 2006, (a non-GAAP measure), increased 37% to $0.26 compared with $0.19 in the first quarter of 2005.
